JOHNSON & JOHNSON

JNJ
Delayed Quote. Delayed  - 10/23 04:10:00 pm
145.24USD +0.11%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2019 2020
Net sales1 82 05981 779
EBITDA1 27 97928 450
Operating profit (EBIT)1 25 59325 020
Operating Margin 31,2%30,6%
Pre-Tax Profit (EBT)1 17 32819 030
Net income1 15 11915 967
Net margin 18,4%19,5%
EPS2 5,636,08
Dividend per Share2 3,753,98
Last update 01/22/202010/14/2020
1 USD in Million
2 USD
Estimates
Finances - Leverage
Fiscal Period: December 2019 2020
Net Debt1 8 4096 543
Net Cash position1 --
Leverage (Debt / EBITDA) 0,30x0,23x
Free Cash Flow1 19 91815 441
ROE (Net Profit / Equities) 39,1%28,1%
Shareholders' equity1 38 66456 834
ROA (Net Profit / Asset) 15,0%11,1%
Assets1 100 753143 383
Book Value Per Share2 22,624,9
Cash Flow per Share2 8,727,11
Capex1 3 4983 496
Capex / Sales 4,26%4,27%
Last update 01/22/202010/15/2020
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2020e 2021e
Capitalization 382 391 M $ -
Entreprise Value (EV) 388 934 M $ 380 384 M $
Valuation 2020e 2021e
P/E ratio (Price / EPS) 23,9x 19,3x
Capitalization / Revenue 4,68x 4,33x
EV / Revenue 4,76x 4,41x
EV / EBITDA 13,7x 12,5x
Yield (DPS / Price) 2,74% 2,92%
Price to book (Price / BVPS) 5,83x 5,37x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 30,6% 31,6%
Operating Leverage (Delta EBIT / Delta Sales) -6,57x 1,43x
Net Margin (Net Profit / Revenue) 19,5% 22,0%
ROA (Net Profit / Asset) 11,1% 12,4%
ROE (Net Profit / Equities) 28,1% 33,2%
Rate of Dividend 65,5% 56,5%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   4,27% 4,20%
Cash Flow / Sales 22,9% 30,0%
Capital Intensity (Assets / Sales) 1,75x 1,77x
Financial Leverage (Net Debt / EBITDA) 0,23x -
Price Earning Ratio
EPS & Dividend